FDA-cleared profile

Sonio Detect

Sonio · Ultrasound · FDA-cleared (510(k))

Authorized purpose: Analyze fetal ultrasound images and clips to automatically detect views, detect anatomical structures within views, and verify view-quality criteria as a concurrent reading aid during acquisition and interpretation.

Clinical role
Concurrent acquisition and interpretation support that labels views, detects structures, verifies quality criteria, and lets the healthcare professional review or override assignments and verification status.
Images and patients
Ultrasound · Fetus and fetal anatomy
Key limitation
Keep in mind: The FDA packet states that Sonio Detect was validated and is intended only for GE, Canon, and Samsung ultrasound devices. Performance statements apply to the tested view, structure, annotation, and quality-criterion endpoints, including only some views and structures, not to an unrestricted fetal-ultrasound claim.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: Analyze fetal ultrasound images and clips to automatically detect views, detect anatomical structures within views, and verify view-quality criteria as a concurrent reading aid during acquisition and interpretation.
  • Which images or clinical context are in scope?Modality: Ultrasound Anatomy or clinical context: Fetus and fetal anatomy Input: Fetal ultrasound images and clips received from an ultrasound machine through the Edge Software; the FDA description covers first-, second-, and third-trimester examinations and real-time processing.
  • Who uses it?Intended users: Qualified and trained healthcare professionals in prenatal ultrasound, including sonographers, maternal-fetal-medicine specialists, OB/GYNs, and fetal surgeons.
  • What does the software produce?Output: Automatically detected views, anatomical structures within supported views, and verified or not-verified standardized quality criteria, including structure presence/absence and zoom level; users can reassign or edit the results.
  • What is its most important limitation?Key limitation: The FDA packet states that Sonio Detect was validated and is intended only for GE, Canon, and Samsung ultrasound devices. Performance statements apply to the tested view, structure, annotation, and quality-criterion endpoints, including only some views and structures, not to an unrestricted fetal-ultrasound claim.

Clinical takeaway. Clinical role: Analyze fetal ultrasound images and clips to automatically detect views, detect anatomical structures within views, and verify view-quality criteria as a concurrent reading aid during acquisition and interpretation.

Evidence takeaway. Evidence from the reviewed source record: Standalone bench testing used 17,885 fetal-ultrasound images from seven clinical sites in the United States, France, and Germany, independent of model-development data. Reported endpoints included 3D-image detection sensitivity 0.980 (95% Wilson CI 0.930-0.994), Doppler-image sensitivity 0.963 (0.908-0.985), annotation-reading proportion correct 0.923 (0.905-0.938), some T1-view sensitivity 0.942, some T2/T3-view sensitivity 0.919, fetal-brain structure sensitivity/specificity 0.857/0.963, fetal-heart structure sensitivity/specificity 0.900/0.982, and brain-view zoom sensitivity/specificity 0.952/0.906 (95% Wilson CIs 0.909-0.976 and 0.758-0.968). Clinical studies were stated to be not applicable for substantial equivalence.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Analyze fetal ultrasound images and clips to automatically detect views, detect anatomical structures within views, and verify view-quality criteria as a concurrent reading aid during acquisition and interpretation.
  • Exact FDA submission
  • Checked 2026-09-09
Workflow role
Concurrent acquisition and interpretation support that labels views, detects structures, verifies quality criteria, and lets the healthcare professional review or override assignments and verification status.
  • Exact FDA submission
  • Checked 2026-09-09
Required input
Fetal ultrasound images and clips received from an ultrasound machine through the Edge Software; the FDA description covers first-, second-, and third-trimester examinations and real-time processing.
  • Exact FDA submission
  • Checked 2026-09-09
Output and clinician action
Automatically detected views, anatomical structures within supported views, and verified or not-verified standardized quality criteria, including structure presence/absence and zoom level; users can reassign or edit the results.
  • Exact FDA submission
  • Checked 2026-09-09
Care setting
Professional prenatal ultrasound imaging environment across first, second, and third trimesters; the FDA device description states a gestational-age range of 11-37 weeks and does not specify a facility type.
  • Exact FDA submission
  • Checked 2026-09-09
Intended users
Qualified and trained healthcare professionals in prenatal ultrasound, including sonographers, maternal-fetal-medicine specialists, OB/GYNs, and fetal surgeons.
  • Exact FDA submission
  • Checked 2026-09-09
Limitations
The FDA packet states that Sonio Detect was validated and is intended only for GE, Canon, and Samsung ultrasound devices. Performance statements apply to the tested view, structure, annotation, and quality-criterion endpoints, including only some views and structures, not to an unrestricted fetal-ultrasound claim.
  • Exact FDA submission
  • Checked 2026-09-09
Evidence summary
Standalone bench testing used 17,885 fetal-ultrasound images from seven clinical sites in the United States, France, and Germany, independent of model-development data. Reported endpoints included 3D-image detection sensitivity 0.980 (95% Wilson CI 0.930-0.994), Doppler-image sensitivity 0.963 (0.908-0.985), annotation-reading proportion correct 0.923 (0.905-0.938), some T1-view sensitivity 0.942, some T2/T3-view sensitivity 0.919, fetal-brain structure sensitivity/specificity 0.857/0.963, fetal-heart structure sensitivity/specificity 0.900/0.982, and brain-view zoom sensitivity/specificity 0.952/0.906 (95% Wilson CIs 0.909-0.976 and 0.758-0.968). Clinical studies were stated to be not applicable for substantial equivalence.
  • Exact FDA submission
  • Checked 2026-09-09

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
Standalone bench testing used 17,885 fetal-ultrasound images from seven clinical sites in the United States, France, and Germany, independent of model-development data. Reported endpoints included 3D-image detection sensitivity 0.980 (95% Wilson CI 0.930-0.994), Doppler-image sensitivity 0.963 (0.908-0.985), annotation-reading proportion correct 0.923 (0.905-0.938), some T1-view sensitivity 0.942, some T2/T3-view sensitivity 0.919, fetal-brain structure sensitivity/specificity 0.857/0.963, fetal-heart structure sensitivity/specificity 0.900/0.982, and brain-view zoom sensitivity/specificity 0.952/0.906 (95% Wilson CIs 0.909-0.976 and 0.758-0.968). Clinical studies were stated to be not applicable for substantial equivalence.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-09
Reported sensitivity
FDA endpoint-specific sensitivity: 3D fetal-ultrasound image detection 0.980 (95% Wilson CI 0.930-0.994); Doppler image detection 0.963 (0.908-0.985); some T1 views 0.942 point estimate; some T2/T3 views 0.919 point estimate; some fetal-brain structures 0.857 point estimate; some fetal-heart structures 0.900 point estimate; brain-view zoom verification 0.952 (95% Wilson CI 0.909-0.976).
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-09

The FDA reports multiple view-, image-type-, structure-, and quality-criterion sensitivities; the baseline's isolated 0.980 value is not a device-wide endpoint.

Reported specificity
FDA endpoint-specific specificity: some fetal-brain structures 0.963 point estimate; some fetal-heart structures 0.982 point estimate; brain-view zoom verification 0.906 (95% Wilson CI 0.758-0.968).
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-09

Specificity is reported only for bounded structure and zoom-quality endpoints; annotation-reading proportion correct and view-detection sensitivities are separate measures.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

Sonio Detect regulatory performance study summary

  • DesignStand-Alone Performance
  • PopulationPopulation described in the exact-submission ACR model card
  • Scopeexact submission
  • Tested versionExact product version not reported; regulatory study summarized for FDA submission K230365
  • Samplen=17885
  • Sites7
  • IndependenceIndependence not established

K230365

ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K230365. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-09
Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Fetal ultrasound images and clips received from an ultrasound machine through the Edge Software; the FDA description covers first-, second-, and third-trimester examinations and real-time processing.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-09 · FDA K230365: Sonio Detect

  2. Routing

    Source context, not route validation: The FDA description states that Edge Software runs on a server on the same network as the ultrasound machine, receives DICOM instances, uploads them to Sonio Cloud, and provides SaaS access through an internet browser; exact current interfaces and local compatibility are not established.

    Scope: Exact FDA submission.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-09 · FDA K230365: Sonio Detect

  3. AI processing

    Source context, not route validation: The exact FDA package describes Sonio Detect as a Software as a Service solution accessed from an internet browser, with Edge Software installed on a server on the same network as the ultrasound machine that uploads DICOM instances to Sonio's Cloud. Current hosting, data flow, and commercial configuration require vendor confirmation.

    Scope: Exact FDA submission. Packet wording: "Sonio Detect is a Software as a Service SaaS solution that aims at helping sonographers," … "Edge Software (described below) to install on a server on the same network as the Ultrasound Machine; ● SaaS accessibility from internet browser.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-11-14 · FDA K230365: Sonio Detect

  4. Returned objects

    Source context, not route validation: Automatically detected views, anatomical structures within supported views, and verified or not-verified standardized quality criteria, including structure presence/absence and zoom level; users can reassign or edit the results.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-09 · FDA K230365: Sonio Detect

  5. Viewer/worklist/report

    Unresolved route: Automatically detected views, anatomical structures within supported views, and verified or not-verified standardized quality criteria, including structure presence/absence and zoom level; users can reassign or edit the results.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-09 · FDA K230365: Sonio Detect

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
The exact FDA package describes Sonio Detect as a Software as a Service solution accessed from an internet browser, with Edge Software installed on a server on the same network as the ultrasound machine that uploads DICOM instances to Sonio's Cloud. Current hosting, data flow, and commercial configuration require vendor confirmation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "Sonio Detect is a Software as a Service SaaS solution that aims at helping sonographers," … "Edge Software (described below) to install on a server on the same network as the Ultrasound Machine; ● SaaS accessibility from internet browser.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

Integration
The FDA description states that Edge Software runs on a server on the same network as the ultrasound machine, receives DICOM instances, uploads them to Sonio Cloud, and provides SaaS access through an internet browser; exact current interfaces and local compatibility are not established.
  • Exact FDA submission
  • Checked 2026-09-09
Security
Sonio's security page states HIPAA and GDPR compliance, HDS-certified cloud providers, SOC 2 Type 2 compliance, encryption at rest and in transit, a web application firewall with intrusion detection, and isolated regional deployments. Vendor-wide.
  • Vendor-wide
  • Checked 2026-10-25

Vendor statement, not an attestation; exact-release scope is not established.

Supported acquisition environment

Scanner manufacturers: All

exact submission · checked 2026-09-01

Confirm currently supported software versions, protocols, and site-specific acquisition configurations.

ACR exact-submission catalog context

ACR AI Central provides an exact-submission model card for Sonio Detect; FDA labeling remains controlling for clinical use, limitations, and performance.

exact submission · checked 2026-09-09
Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K230365
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
Ultrasound
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-09
Anatomy
Fetus and fetal anatomy
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-09
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2023-07-25
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-20Last searched
25Fields reviewed
10Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, vendor documentation, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not verified - checked 2026-09-09 - Exact FDA submission

    No public price or quote for the exact K230365 configuration was established in this review.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-09-09 - Exact FDA submission

    No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-09-09 - Exact FDA submission

    Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.

  • Monitoring: Not verified - checked 2026-09-09 - Exact FDA submission

    Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.

8 sources - 3 history items

Source ledger

  1. FDA K230365: Sonio Detect

    U.S. Food and Drug Administration - Published 2023-07-25 - Accessed 2026-09-09

    Scope: identity, clinicalUse, modality, anatomy, workflow, evidence, implementation, deployment

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. Sonio Detect model card (K230365)

    American College of Radiology - Published 2026-06-26 - Accessed 2026-09-01

    Scope: intendedUsers, output, limitations, reportedSensitivity, evidenceSummary, anatomy, evidenceStudies, implementationCapabilities

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. openFDA exact recall query for K230365

    U.S. Food and Drug Administration - Accessed 2026-09-09

    Scope: postmarketSafety

  8. Sonio Security and Medical Device Regulatory Info

    Sonio - Accessed 2026-10-25

    Scope: security

Research history

  1. K230365 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    fda record reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K260234

MSK Go

Smart Alfa Teknoloji San. Ve Tic. A.S.

Authorized purpose: Assist qualified MSK-ultrasound professionals by highlighting supported joint anatomy and detection completeness on compatible adult ultrasound images; it is not a diagnostic device.

Modality
Ultrasound
Anatomy
Musculoskeletal joints: shoulder, elbow, wrist/hand, knee, and ankle/foot.
Decision
2026-05-21
FDA-cleared K252433

Sonio Detect (v3)

Sonio

Authorized purpose: Sonio Detect v3 analyzes fetal ultrasound images and clips to detect views and anatomical structures and to check labeled image-quality characteristics during acquisition or interpretation.

Modality
Ultrasound
Anatomy
Fetal anatomy
Decision
2026-03-16
FDA-cleared K250959

BioticsAI

Bioticsai, Inc.

Authorized purpose: BioticsAI assists healthcare professionals during and after fetal ultrasound acquisition and interpretation by detecting views and anatomical structures and facilitating quality-criteria verification on DICOM images and frames; it is a concurrent reading aid for the labeled GE ultrasound and prenatal population.

Modality
Ultrasound
Anatomy
Obstetric/Fetal
Decision
2025-12-22

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history